Balanced covariates with response adaptive randomization

Response adaptive randomization (RAR) methods for clinical trials are susceptible to imbalance in the distribution of influential covariates across treatment arms. This can make the interpretation of trial results difficult, because observed differences between treatment groups may be a function of the covariates and not necessarily because of the treatments themselves. We propose a method for balancing the distribution of covariate strata across treatment arms within RAR. The method uses odds ratios to modify global RAR probabilities to obtain stratum-specific modified RAR probabilities. We provide illustrative examples and a simple simulation study to demonstrate the effectiveness of the strategy for maintaining covariate balance. The proposed method is straightforward to implement and applicable to any type of RAR method or outcome.

[1]  R. Silbergleit,et al.  Hyperbaric oxygen brain injury treatment (HOBIT) trial: a multifactor design with response adaptive randomization and longitudinal modeling , 2016, Pharmaceutical statistics.

[2]  Feifang Hu,et al.  ST ] 1 7 O ct 2 00 6 ASYMPTOTIC PROPERTIES OF COVARIATE-ADJUSTED ADAPTIVE DESIGNS , 2006 .

[3]  D R Taves,et al.  Minimization: A new method of assigning patients to treatment and control groups , 1974, Clinical pharmacology and therapeutics.

[4]  B. Freidlin,et al.  Outcome--adaptive randomization: is it useful? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  W. Rosenberger,et al.  The theory of response-adaptive randomization in clinical trials , 2006 .

[6]  Jing Ning,et al.  Response‐adaptive randomization for clinical trials with adjustment for covariate imbalance , 2010, Statistics in medicine.

[7]  Uttam Bandyopadhyay,et al.  Adaptive designs for normal responses with prognostic factors , 2001 .

[8]  J. Kimmelman,et al.  Are outcome-adaptive allocation trials ethical? , 2015, Clinical trials.

[9]  Donald A Berry,et al.  The Brave New World of clinical cancer research: Adaptive biomarker‐driven trials integrating clinical practice with clinical research , 2015, Molecular oncology.

[10]  D. Berry,et al.  Adaptive assignment versus balanced randomization in clinical trials: a decision analysis. , 1995, Statistics in medicine.

[11]  D. Berry Adaptive clinical trials: the promise and the caution. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Satoshi Morita,et al.  Bayesian response adaptive randomization using longitudinal outcomes. , 2015, Pharmaceutical statistics.

[13]  F. Hu,et al.  Asymptotic properties of covariate-adaptive randomization , 2012, 1210.4666.

[14]  Uttam Bandyopadhyay,et al.  A covariate adjusted two‐stage allocation design for binary responses in randomized clinical trials , 2007, Statistics in medicine.

[15]  Peter F Thall,et al.  Continuous Bayesian adaptive randomization based on event times with covariates , 2006, Statistics in medicine.

[16]  P. Thall,et al.  Covariate‐adjusted adaptive randomization in a sarcoma trial with multi‐stage treatments , 2005, Statistics in medicine.

[17]  Feifang Hu,et al.  A new family of covariate-adjusted response adaptive designs and their properties , 2008, 0812.3691.

[18]  M Zelen,et al.  The randomization and stratification of patients to clinical trials. , 1974, Journal of chronic diseases.

[19]  P. Thall,et al.  Practical Bayesian adaptive randomisation in clinical trials. , 2007, European journal of cancer.

[20]  C B Begg,et al.  A treatment allocation procedure for sequential clinical trials. , 1980, Biometrics.

[21]  G. Yin,et al.  Worth Adapting? Revisiting the Usefulness of Outcome-Adaptive Randomization , 2012, Clinical Cancer Research.

[22]  Pocock Sj,et al.  Allocation of patients to treatment in clinical trials. , 1979 .

[23]  Donald A. Berry,et al.  Design of a Bayesian adaptive phase 2 proof-of-concept trial for BAN2401, a putative disease-modifying monoclonal antibody for the treatment of Alzheimer's disease , 2016, Alzheimer's & dementia.

[24]  S. Pocock,et al.  Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.

[25]  Oleksandr Sverdlov,et al.  Adaptive Randomization for Clinical Trials , 2012, Journal of biopharmaceutical statistics.

[26]  Kristine Broglio,et al.  Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. , 2013, Journal of clinical epidemiology.

[27]  Atanu Biswas,et al.  Covariate-adjusted response-adaptive designs for longitudinal treatment responses: PEMF trial revisited , 2012, Statistical Methods in Medical Research.

[28]  Donald A Berry Commentary on Hey and Kimmelman , 2015, Clinical trials.

[29]  W. Rosenberger,et al.  Covariate‐Adaptive Randomization , 2015 .

[30]  Ying Yuan,et al.  A Bayesian response‐adaptive covariate‐balanced randomization design with application to a leukemia clinical trial , 2011, Statistics in medicine.

[31]  Jun Shao,et al.  A theory for testing hypotheses under covariate-adaptive randomization , 2010 .

[32]  Li-Xin Zhang,et al.  Asymptotic properties of covariate-adjusted response-adaptive designs , 2006 .